- TriSalus Life Sciences press release (NASDAQ:TLSI): Q1 GAAP EPS of -$0.39 misses by $0.17.
- Revenue of $9.2M (+41.5% Y/Y) beats by $0.16M.
-
Updated 2025 Guidance
TriSalus is confirming its revenue guidance of at least 50% growth due to continued commercial momentum